Rubella News and Research

RSS

Children need to be up-to-date on immunizations before heading back-to-school

While we prepare our children to go back to school, parents should check and make sure their children are current on all vaccinations before the start of the school year or they may not be able to start on the first day.

17 Aug 2017

Binding Site launches new antigens and antibodies for infectious/contagious diseases

The Immunologicals Group of The Binding Site is pleased to announce the launch of a number of new monoclonal antibodies and recombinant antigens focused on a variety of infectious/contagious disease states – including Cytomegalovirus (CMV), Hepatitis, HIV, Rubella, Syphilis, and Toxoplasmosis.

From Binding Site 29 Jul 2017

ECDC highlights need to scale-up efforts for eliminating viral hepatitis in Europe

An estimated 4.7 million Europeans are living with chronic hepatitis B and almost 4 million (3.9) with chronic hepatitis C infection.

26 Jul 2017

Risk Analysis publishes special issue focused on global measles and rubella eradication

Despite goals in every World Health Organization region to eliminate measles by 2020, measles and rubella continue to cause relatively high levels of morbidity and mortality.

25 Jul 2017

Global multi-stakeholder partnerships improve health of women, children, and adolescents

Globally, the health and well-being of women, children, and adolescents are improving faster than at any point in history, even in the poorest nations.

19 Jul 2017

Measles outbreak - 35 reported deaths in Europe

Over the last 12 month, there have been 35 reported deaths due to the ongoing measles outbreak in the WHO European Region says a new report.

12 Jul 2017

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments.

6 Jul 2017

Study develops dissolvable microneedle patches for administering influenza vaccine

Study findings published online in The Lancet on June 27, 2017 have found that an experimental patch of dissolving microneedles can produce robust immune responses for influenza. The microneedle patches can be administered safely and can be a substitute for the needle-and-syringe vaccination. With further advancements, they could remove the uneasiness in using an injection and inconvenience of visiting a flu clinic, as well as offering cost benefits.

28 Jun 2017

Bandage-strip sized microneedle patches can transform flu vaccination method

A National Institutes of Health-funded study led by a team at the Georgia Institute of Technology and Emory University has shown that an influenza vaccine can produce robust immune responses and be administered safely with an experimental patch of dissolving microneedles.

28 Jun 2017

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

St. Jude Children's Research Hospital and the Serum Institute of India have signed a licensing agreement to complete development and commercialization of a St. Jude vaccine against the respiratory syncytial virus (RSV), the virus that causes croup and lower respiratory infections. RSV kills about 160,000 people, primarily infants, worldwide each year.

10 May 2017

ECDC guidance aims to improve antenatal screening for infections to avoid mother-to-child transmission

Transmission of infections with HIV, hepatitis B, syphilis or rubella from mother to child before and during birth as well as in infancy still occur across Europe - despite existing prevention methods.

21 Mar 2017

Study: More than ten million lives saved by discovery of cell strain in 1962

Nearly 200 million cases of polio, measles, mumps, rubella, varicella, adenovirus, rabies and hepatitis A -- and approximately 450,000 deaths from these diseases -- were prevented in the U.S. alone between 1963 and 2015 by vaccination, researchers estimate.

3 Mar 2017

Researchers examine risk factors for B Cell Non-Hodgkin Lymphoma in Israeli, Palestinian populations

Israeli and Palestinian researchers have conducted a large scale epidemiological study examining risk factors for a form of Non-Hodgkin Lymphoma in these two populations.

21 Feb 2017

Most Americans believe preventive health benefits of childhood vaccines outweigh risks

Despite debate about the safety of childhood vaccines among some groups in the public, an overwhelming majority of Americans (82%) support requiring children attending public school to be vaccinated for measles, mumps and rubella (MMR), according to a new Pew Research Center survey.

2 Feb 2017

Johns Hopkins researchers uncover mechanism in chikungunya virus that controls disease severity

Researchers led by the Johns Hopkins Bloomberg School of Public Health have identified a mechanism by which the chikungunya virus infects healthy cells and controls how severe the disease it causes will be, a mechanism they believe can be found in a number of other related viruses for which there are no treatments or licensed vaccines.

31 Jan 2017

First symptoms of meningitis

Thankfully, meningitis is a rare condition. Although it can occur in anyone, it's more prevalent in babies and young children, with young people and students being the next most at risk group. In the early stages, it can be very difficult to tell meningitis apart from milder diseases, as it often resembles other common viral illnesses. Symptoms of the disease can develop very quickly.

19 Jan 2017

Texas A&M specialist explains what people need to know about mumps

Mumps may seem like a contagion relegated to history books, but like many other diseases of the past now preventable with a vaccine, mumps has been making a resurgence.

20 Dec 2016

Vaccine-related rubella virus causes harm in some patients with primary immunodeficiency disorders

Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine.

7 Nov 2016

Measles complication that kills children more common than previously thought

A complication of measles that kills children years after they have the infection is more common than thought, according to a study being presented at IDWeek 2016.

31 Oct 2016

Poor, remote Indigenous Australians have increased risk of sexually transmissible infections

A unique 21-year study of more than 2.4 million cases of infectious disease across Australia reveals a major social divide where being poorer, living remotely or being an Indigenous Australian means having an increased risk of sexually transmissible infections (STIs).

25 Oct 2016